Prediction of recurrence or metastasis of malignant tumors by assessment of their growth abilities and its clinical application
Prediction of recurrence or metastasis of malignant tumors by assessment of their growth abilities and its clinical application
批准号:
03454316
负责人:
TANIGAWA Nobuhiko
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It was recently demonstrated that proliferative activity is prognostically more significant than DNA ploidy petterns. The proliferative status of tumor cells has been roughly determined by several factors, including the mitotic index, S-phase fraction, labeling index and tumor colony formation. However, those fasctors have been fegarded as being less important than tumor staging. Advances in tissue culture techniques ha have made it possible for cells from fresh solid tumors to proliferate in semisolid medium. In a thymidine incorporation assay, which we originally developed, it is possible to measure the incorporation of tritiated thymidine by tumor cells. The scope of this study is to evaluate the clonicopathological correlations and the prognostic value of tritiated thymidine uptake in gastric and colorectal cancer patients.In 173 patients with operable gastric cancer and in 127 patients with colorectal carcinoma, thymidine uptake by tumor cells cultured in a semi solid medium was medsured and was compared the influence of various parameters on survival by**ivariate and multivariate analysis. Patients in the high-uptake had a poorerprognosis than those in the low-uptake, both with gastric and colorectal cancer. Mulativariate analysis showed that thymidine uptake was one of the variables strongly associated with survival in our study population with gastric or colorectal carcinoma. Thus, it is concluded that thymidine uptake by tumor cells is an independent prognostic indicator which may be useful for selecting patients with gastric and colorectal carcinoma who wouldbenetil from more aggressive treatment.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nobuhiko Tanigawa,Hideki Morimoto,Naochika Dohmae,Takumi Shimomatsuya,Kohji Takahashi and Ryusuke Muraoka: "In vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumour clonogenic assay and the thymidi
Nobuhiko Tanikawa、Hideki Morimoto、Naochika Dohmae、Takumi Shimomatsuya、Kohji Takahashi 和 Ryusuke Muraoka:“利用人类肿瘤克隆形成试验和胸腺嘧啶核苷评估胃癌和结直肠癌细胞的体外生长能力和化疗敏感性
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
谷川 允彦: "消化器癌転移病変の特性" 日本消化器外科学会雑誌. 24. 1101-1106 (1991)
Masahiko Tanikawa:“胃肠癌转移病变的特征”日本胃肠外科学会杂志 24. 1101-1106 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takumi Shimomatsuya: "Proliferative activity of human tumors:assessment uisng bromodeoxyuridine and flow cytometry" Jpn J Cancer Res. 82. 357-362 (1991)
Takumi Shimomatsuya:“人类肿瘤的增殖活性:使用溴脱氧尿苷和流式细胞术进行评估”Jpn J Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hideki Morimoto, Nobuhiko Tanigawa: "The significance of postoperative early chemotherapy for locogegional lymph node metastasis of gastric and colorectal cancer." Oncology. 48. 210-214 (1991)
Hideki Morimoto、Nobuhiko Tanikawa:“术后早期化疗对胃癌和结直肠癌局部淋巴结转移的意义”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hideki Morimoto,: "The significance of postoperative early chemo-therapy for locoregional lymph node metastasis of gastric and colorectal." Oncology. 48. 210-214 (1991)
Hideki Morimoto:“术后早期化疗对胃和结直肠局部淋巴结转移的意义。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
In vitro chemosensitivity test to predict chemosensicivity for paclitaxel, using human gastric carcinoma tissues.
-
批准号:16209041
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.95万
-
财政年份:2004
-
负责人:TANIGAWA Nobuhiko
-
依托单位:
Medical treatment research by the gene cluster (EPR-1, dCK, and TP) which guides antineoplastic drug susceptibility reinforcement
-
批准号:13470262
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:2001
-
负责人:TANIGAWA Nobuhiko
-
依托单位:
Gene therapy for augmentation chemosentivities to anticancer drugs with improvement of therapeutic index
-
批准号:10470265
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.1万
-
财政年份:1998
-
负责人:TANIGAWA Nobuhiko
-
依托单位:
Application of a new drug screening method for clinical chemotherapy
-
批准号:63870051
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$3.78万
-
财政年份:1988
-
负责人:TANIGAWA Nobuhiko
-
依托单位:
Modification of Anti-cancer Drug Formula and Its Local Administration
-
批准号:63480301
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.3万
-
财政年份:1988
-
负责人:TANIGAWA Nobuhiko
-
依托单位:
海外基金